Cingulate Inc Share Price

NASDAQ: CING

Small Cap

$3.70

-0.23

(-5.85%)

as on September 18, 2025 at 1:29 am IST

$₹

Cingulate Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$3.62
Day's Price Range
$3.93
$3.7
2.16%
Downside
6.22%
Upside
52 Week's Low
52 Week's High
$3.02
52-Week Price Range
$6.01
$3.7
18.38%
Downside
62.43%
Upside

Cingulate Inc share price movements today

Previous Close: $3.93
Open: $3.83
Volume: 524.3K
Day's Low - High: $3.62 - $3.93
52 Week Low - High: $3.02 - $6.01

Cingulate Inc Historical Returns

1 Month Return: -11.06 %
3 Month Return: -16.85 %
1 Year Return: -25.1 %
3 Year Return: -98.8 %
5 Year Return: 0 %

Cingulate Inc Stock Fundamentals & Key Indicators

Check Cingulate Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$22.0M

EPS (TTM)

-3.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.03

Industry PE ratio

P/B Ratio

0.0291

PEG Ratio

EBITDA

-17.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-417.77%

Cingulate Inc Stock Valuation

Track how Cingulate Inc P/E has moved over time to understand its valuation trends.

Cingulate Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 18, 2025

Industry (0.00x)

September 18, 2025

Today (0.03x)

September 18, 2025

Highest (-0.26x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 0.03x

Cingulate Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cingulate Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cingulate Inc	BUY	$22.0M	NA	0.03	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	248.74%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Cingulate Inc Stock including INR - Dollar returns

The Cingulate Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cingulate Inc investment value today

Current value as on today

₹79,497

Returns

₹20,503

(-20.5%)

Returns from Cingulate Inc Stock

₹25,101 (-25.1%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Cingulate Inc Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Cingulate Inc. Average target price of $27.71

Cingulate Inc Share Price Target

Get share price movements and forecasts by analysts on Cingulate Inc.

What analysts predicted

86.65%UPSIDE

Target Price

$27.71

Current Price

$3.7

Analyzed by

10 Analysts

Target

$27.71

Cingulate Inc target price $27.71, a slight upside of 86.65% compared to current price of $3.7. According to 10 analysts rating.

Cingulate Inc Stock's Interest Amongst Investors

Search interest for Cingulate Inc Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-26% versus previous 30 day period

Cingulate Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	3,849	-	-	-3,849	-	-	12,982	-	-
Gross Profit	0	3,849	-6,362	-5	-2	0	-3,282	6,491	0	0
Operating Income	-4	-3	-6	-5	-2	-3	-3	-6	-3	-4
EBITDA	-4	-3	-6	-5	-2	-3	-3	-6	-3	-4
Interest Expense	0	154	253	0	408	3	50	0	96	138
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-4	-6	-5	-2	-3	-3	-6	-3	-4
Income Tax Expense	-3	155	6,108	0	0	-	-	-	-	-
Net Income	0	-4	-6	-5	-2	-3	-3	-6	-3	-4
Net Profit Margin	0.00%	-0.10%	0.00%	0.00%	0.08%	0.00%	0.00%	-0.05%	0.00%	0.00%

Cingulate Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0
Operating Income	-11	-7	-20	-17	-22	-15
EBITDA	-11	-6	-19	-17	-22	-14
Interest Expense	-	0	0	0	0	0
Depreciation	0	0	0	0	0	0
Income Before Tax	-11	-7	-20	-17	-23	-15
Income Tax Expense	0	0	0	0	0	0
Net Income	-11	-7	-20	-17	-23	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cingulate Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-6	-5	-6	-2	-3	-3	-6	-3	-4
Operating Cash Flow	-4	-4	-	-8	-1	-3	-4	-4	-4
Investing Cash Flow	-	-	-	0	0	0	0	-	0
Financing Cash Flow	3	5	-	9	1	13	6	1	4
Change in Cash	-1	1	-	1	0	9	2	-2	0

Cingulate Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-7	-20	-17	0	-15
Operating Cash Flow	-6	-10	-15	-15	-18
Investing Cash Flow	0	0	0	0	0
Financing Cash Flow	7	26	4	9	30
Change in Cash	0	15	-11	-5	12

Global Institutional Holdings in Cingulate Inc

Funds	Holdings
Citigroup Inc	0%

Insights on Cingulate Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 210.3%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 93.5%
NEGATIVE IMPACT
Price Dip
In the last 1 month, CING stock has moved down by -11.1%

About Cingulate Inc

Cingulate Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing, and commercialization of pharmaceutical products that utilize its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles. It focuses on the treatment of attention deficit/hyperactivity disorder (ADHD). The Company is in the development of two lead product candidates, such as CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). The Company’s CTx-1301 and CTx-1302 are being developed for the treatment of ADHD in the three core patient segments: children (ages 6-12), adolescents (ages 13-17), and adults (ages18+). In addition, the Company has a third product to treat anxiety, CTx-2103, in a formulation stage. Its CTx-1301, CTx-1302 and CTx-2103 drug candidates contain three releases of active pharmaceutical ingredient combined into one small tablet dosage form.

Organisation	Cingulate Inc
Headquarters	1901 West 47th Place, Kansas City, KS, United States, 66205
CEO	Ms. Jennifer L. Callahan CPA
E-voting on shares	Click here to vote

Key Management of Cingulate Inc

Name	Title
Thomas Dalton	Vice President of Investor & Public Relations
Mr. Nilay Patel J.D.	Chief Legal Officer
Mr. John A. Roberts M.B.A.	Executive Chairman
Ms. Jennifer L. Callahan CPA	Interim CEO, Senior VP, CFO & Secretary
Dr. Shane J. Schaffer Pharm.D.	Co-Founder, CEO & Chairman of the Board (Leave of Absence)
Dr. Raul R. Silva M.D.	Co-Founder, Executive VP & Chief Science Officer
Dr. Matthew N. Brams M.D.	Co-Founder, Executive VP & Chief Medical Officer

FAQs

What is Cingulate Inc share price today?

Cingulate Inc share price today is $3.7 as on September 18, 2025 at 1:29 am IST at the close of the market. Cingulate Inc share today touched a day high of $3.93 and a low of $3.62.

What is the 52 week high and 52 week low for Cingulate Inc share?

Cingulate Inc share touched a 52 week high of $6.01 on July 21, 2025 and a 52 week low of $3.02 on November 7, 2024. Cingulate Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $3.7,which is 38.44% down from its 52 week high and 22.52% up from its 52 week low.

What is Cingulate Inc's market capitalisation today?

Cingulate Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Cingulate Inc Stock (CING) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cingulate Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cingulate Inc Shares that will get you 0.4054 shares as per Cingulate Inc share price of $3.7 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Cingulate Inc Stock (CING) from India?

Indian investors can start investing in Cingulate Inc (CING) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 1:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Cingulate Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 1:38 pm IST). Based on Cingulate Inc share’s latest price of $3.7 as on September 18, 2025 at 1:29 am IST, you will get 2.7027 shares of Cingulate Inc. Learn more about fractional shares .